Healthcare

NCQA Awarded New HRSA Task Order to Expand Access to Patient-Centered and Behavioral Health Care

Helping FQHCs deliver whole-person care through PCMH Recognition and Distinction in Behavioral Health Integration. WASHINGTON, DC / ACCESS Newswire /…

2 months ago

Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting

Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and…

2 months ago

Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech’s 24% YoY Revenue Growth for the Third Quarter of 2025

Sportstech Revenue Growth Accelerated from 18% YoY in Second Quarter, and is Expected to Surpass 30% YoY in Fourth QuarterCurrent…

2 months ago

AllStar Health Brands Updates on Exciting Developments and Expansions

MIAMI, FL / ACCESS Newswire / November 5, 2025 / AllStar Health Brands (ALST:OTCIQ) is pleased to share several significant…

2 months ago

Bausch Health’s OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL,…

2 months ago

TailorMed Showcases Innovative Patient-Facing Solution at Becker’s Fall Chief Pharmacy Officer Summit

TailorMed Connect Gives Patients Direct Access to Critical Support While Scaling Health Systems' Impact NEW YORK, NY / ACCESS Newswire…

2 months ago

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a…

2 months ago

MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

MaxCyte will now host its earnings conference call on November 12, 2025 Management will present at the Stifel Healthcare Conference…

2 months ago

Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide…

2 months ago